Clinical Trials Logo

Clinical Trial Summary

The objective of the INCORPORATE trial is to evaluate whether an intentional invasive strategy with ischemia targeted, reasonably complete coronary revascularization and optimal medical therapy is superior as compared to a primary conservative approach and optimal medical therapy alone in terms of spontaneous myocardial infarct-free and overall survival in patients with severe peripheral artery disease, underwent peripheral artery revascularization due to critical limb ischemia.

The INCORPORATE trial is designed to be non-blinded, open-label, prospective 1:1 randomized controlled multicentric trial.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03712644
Study type Interventional
Source Medical University of Graz
Contact Gabor G Toth, MD, PhD
Phone 004331638512544
Email gabor.g.toth@medunigraz.at
Status Recruiting
Phase N/A
Start date July 11, 2018
Completion date August 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT00380016 - Catheter-Based Treatment of Cardiovascular Disease N/A
Completed NCT01853592 - Gadofosveset Trisodium for Heart Imaging Studies
Completed NCT01837823 - YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering Phase 2